LASA SUPERGENERICS
|
The Current P/E Ratio of LASA SUPERGENERICS is -3.92.
Share Price | ₹11.6 | Jul 02,2025 |
Market Cap | ₹57.9 Cr | |
Earnings-TTM | ₹-14.8 Cr | TTM-Standalone Results |
Price/Earnings | -3.92x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of LASA SUPERGENERICS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹57.9 Cr] as on Jul 02,2025
(/) Earnings [ ₹-14.8 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ -3.92x ]
Thus, for LASA SUPERGENERICS , the investors are currently willing to pay -3.92 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of LASA SUPERGENERICS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of LASA SUPERGENERICS over the last five years.
Historical PE (Price/Earnings) ratio chart of LASA SUPERGENERICS
PE Ratio Performance Analysis for LASA SUPERGENERICS
- LASA SUPERGENERICS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 8.51x.
- LASA SUPERGENERICS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LASA SUPERGENERICS 's p/e ratio peaked in Mar2020 at 31.83x.
- LASA SUPERGENERICS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does LASA SUPERGENERICS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
LASA SUPERGENERICS | -14.76 | -3.92 | 57.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.66 | 402,584.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 83.13 | 182,147.0 |
CIPLA LTD | 5,291.05 | 22.86 | 120,941.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 59.30 | 113,325.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 18.61 | 106,138.0 |
MANKIND PHARMA LTD | 2,003.22 | 49.17 | 98,491.5 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.71 | 100,176.0 |
LUPIN LTD | 3,306.26 | 27.18 | 89,863.5 |
AUROBINDO PHARMA LTD | 3,515.26 | 19.13 | 67,242.3 |
ABBOTT INDIA LTD | 1,414.44 | 53.17 | 75,200.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs LASA SUPERGENERICS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -3.92x |
Max industry PE | 83.13x |
Median industry PE | 27.18x |
Average industry PE | 35.18x |
You may also like the below Video Courses